Följ
Nathalie Scholler
Nathalie Scholler
Senior Director, Oncology Research, Gilead Sciences
Verifierad e-postadress på gilead.com
Titel
Citeras av
Citeras av
År
ICOS-based chimeric antigen receptors program bipolar TH17/TH1 cells
S Guedan, X Chen, A Madar, C Carpenito, SE McGettigan, MJ Frigault, ...
Blood, The Journal of the American Society of Hematology 124 (7), 1070-1080, 2014
4182014
Soluble member (s) of the mesothelin/megakaryocyte potentiating factor family are detectable in sera from patients with ovarian carcinoma
N Scholler, N Fu, YI Yang, Z Ye, GE Goodman, KE Hellström, I Hellström
Proceedings of the National Academy of Sciences 96 (20), 11531-11536, 1999
3981999
Ovarian cancer biomarker performance in prostate, lung, colorectal, and ovarian cancer screening trial specimens
DW Cramer, RC Bast Jr, CD Berg, EP Diamandis, AK Godwin, P Hartge, ...
Cancer prevention research 4 (3), 365-374, 2011
3702011
A universal strategy for adoptive immunotherapy of cancer through use of a novel T-cell antigen receptor
K Urbanska, E Lanitis, M Poussin, RC Lynn, BP Gavin, S Kelderman, J Yu, ...
Cancer research 72 (7), 1844-1852, 2012
3382012
A mouse to human search for plasma proteome changes associated with pancreatic tumor development
VM Faca, KS Song, H Wang, Q Zhang, AL Krasnoselsky, LF Newcomb, ...
PLoS medicine 5 (6), e123, 2008
3132008
Assessing lead time of selected ovarian cancer biomarkers: a nested case–control study
GL Anderson, M McIntosh, L Wu, M Barnett, G Goodman, JD Thorpe, ...
Journal of the National Cancer Institute 102 (1), 26-38, 2010
2662010
Combining CA 125 and SMR serum markers for diagnosis and early detection of ovarian carcinoma
MW McIntosh, C Drescher, B Karlan, N Scholler, N Urban, KE Hellstrom, ...
Gynecologic oncology 95 (1), 9-15, 2004
2572004
CA125 in ovarian cancer
N Scholler, N Urban
Future Medicine Ltd 1 (4), 513-523, 2007
2542007
Safety and feasibility of anti-CD19 CAR T cells with fully human binding domains in patients with B-cell lymphoma
JN Brudno, N Lam, D Vanasse, Y Shen, JJ Rose, J Rossi, A Xue, A Bot, ...
Nature medicine 26 (2), 270-280, 2020
2212020
Use of a Symptom Index, CA125, and HE4 to predict ovarian cancer
MR Andersen, BA Goff, KA Lowe, N Scholler, L Bergan, CW Drescher, ...
Gynecologic oncology 116 (3), 378-383, 2010
2212010
Redirected antitumor activity of primary human lymphocytes transduced with a fully human anti-mesothelin chimeric receptor
E Lanitis, M Poussin, IS Hagemann, G Coukos, R Sandaltzopoulos, ...
Molecular Therapy 20 (3), 633-643, 2012
2162012
A framework for evaluating biomarkers for early detection: validation of biomarker panels for ovarian cancer
CS Zhu, PF Pinsky, DW Cramer, DF Ransohoff, P Hartge, RM Pfeiffer, ...
Cancer prevention research 4 (3), 375-383, 2011
2012011
Bead-based ELISA for validation of ovarian cancer early detection markers
N Scholler, M Crawford, A Sato, CW Drescher, KC O'Briant, N Kiviat, ...
Clinical cancer research 12 (7), 2117-2124, 2006
1922006
Cutting edge: CD83 regulates the development of cellular immunity
N Scholler, M Hayden-Ledbetter, A Dahlin, I Hellstrom, KE Hellström, ...
The Journal of Immunology 168 (6), 2599-2602, 2002
1752002
Anti-CD70 antibody-drug conjugates and their use for the treatment of cancer and immune disorders
CL Law, AF Wahl, N Scholler, LA Pestano
US Patent 7,662,387, 2010
158*2010
Influence of ovarian cancer risk status on the diagnostic performance of the serum biomarkers mesothelin, HE4, and CA125
CA Shah, KA Lowe, P Paley, E Wallace, GL Anderson, MW McIntosh, ...
Cancer Epidemiology Biomarkers & Prevention 18 (5), 1365-1372, 2009
1462009
Novel recombinant human b7-h4 antibodies overcome tumoral immune escape to potentiate T-cell antitumor responses
D Dangaj, E Lanitis, A Zhao, S Joshi, Y Cheng, R Sandaltzopoulos, HJ Ra, ...
Cancer research 73 (15), 4820-4829, 2013
1372013
Correlation of serum HE4 with tumor size and myometrial invasion in endometrial cancer
E Kalogera, N Scholler, C Powless, A Weaver, R Drapkin, J Li, SW Jiang, ...
Gynecologic oncology 124 (2), 270-275, 2012
1342012
CD83 is a sialic acid-binding Ig-like lectin (Siglec) adhesion receptor that binds monocytes and a subset of activated CD8+ T cells
N Scholler, M Hayden-Ledbetter, KE Hellström, I Hellström, ...
The Journal of Immunology 166 (6), 3865-3872, 2001
1342001
Genetic and pharmacologic inhibition of complement impairs endothelial cell function and ablates ovarian cancer neovascularization
S Nunez-Cruz, PA Gimotty, MW Guerra, DC Connolly, YQ Wu, ...
Neoplasia 14 (11), 994-IN1, 2012
1332012
Systemet kan inte utföra åtgärden just nu. Försök igen senare.
Artiklar 1–20